Bill S-201: National Framework on Sickle Cell Disease Act

This bill primarily affects healthcare providers, medical laboratories, and blood collection organizations across Canada. Physicians, nurses, and other health professionals may need to undertake additional training on sickle cell disease diagnosis and treatment as new national standards are established. Neonatal screening laboratories and hospitals delivering babies would need to implement universal screening protocols. Blood collection agencies like Canadian Blood Services could see new requirements to promote diverse blood donation. The bill also signals potential future impacts for employers and insurers if disability benefit eligibility criteria are expanded or if public drug plans add sickle cell treatments, though these are subject to further analysis rather than immediate mandates.